136 related articles for article (PubMed ID: 34196651)
1. Association Between Neuronal Autoantibodies and Cognitive Impairment in Patients With Lung Cancer.
Bartels F; Wandrey MM; Aigner A; Strönisch T; Farmer K; Rentzsch K; Tessmer A; Grohé C; Finke C
JAMA Oncol; 2021 Sep; 7(9):1302-1310. PubMed ID: 34196651
[TBL] [Abstract][Full Text] [Related]
2. Neuronal autoantibodies associated with cognitive impairment in melanoma patients.
Bartels F; Strönisch T; Farmer K; Rentzsch K; Kiecker F; Finke C
Ann Oncol; 2019 May; 30(5):823-829. PubMed ID: 30840061
[TBL] [Abstract][Full Text] [Related]
3. High prevalence of neuronal surface autoantibodies associated with cognitive deficits in cancer patients.
Finke C; Bartels F; Lütt A; Prüss H; Harms L
J Neurol; 2017 Sep; 264(9):1968-1977. PubMed ID: 28785798
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with perceived cognitive impairment in patients with advanced lung cancer: a cross-sectional analysis.
Takemura N; Ho MH; Cheung DST; Lin CC
Support Care Cancer; 2022 Nov; 30(11):9607-9614. PubMed ID: 36178636
[TBL] [Abstract][Full Text] [Related]
5. Neuronal autoantibody titers in the course of small-cell lung carcinoma and platinum-associated neuropathy.
Galanis E; Frytak S; Rowland KM; Sloan JA; Lennon VA
Cancer Immunol Immunother; 1999; 48(2-3):85-90. PubMed ID: 10414461
[TBL] [Abstract][Full Text] [Related]
6. Association of cerebrospinal fluid brain-binding autoantibodies with cognitive impairment in post-COVID-19 syndrome.
Franke C; Boesl F; Goereci Y; Gerhard A; Schweitzer F; Schroeder M; Foverskov-Rasmussen H; Heine J; Quitschau A; Kandil FI; Schild AK; Finke C; Audebert HJ; Endres M; Warnke C; Prüss H
Brain Behav Immun; 2023 Mar; 109():139-143. PubMed ID: 36657623
[TBL] [Abstract][Full Text] [Related]
7. Potential paraneoplastic syndromes and selected autoimmune conditions in patients with non-small cell lung cancer and small cell lung cancer: A population-based cohort study.
Miret M; Horváth-Puhó E; Déruaz-Luyet A; Sørensen HT; Ehrenstein V
PLoS One; 2017; 12(8):e0181564. PubMed ID: 28767671
[TBL] [Abstract][Full Text] [Related]
8. Paraneoplastic autoimmunity and small-cell lung cancer: Neurological and serological accompaniments.
Zekeridou A; Majed M; Heliopoulos I; Lennon VA
Thorac Cancer; 2019 Apr; 10(4):1001-1004. PubMed ID: 30810271
[TBL] [Abstract][Full Text] [Related]
9. Humoral Immune Response against Neural Antigens and Its Effects on Cognition in Lung Cancer Patients.
Rybacka-Mossakowska J; Ramlau R; Gazdulska J; Gołda-Gocka I; Kozubski W; Michalak S
Adv Exp Med Biol; 2016; 911():59-66. PubMed ID: 26987335
[TBL] [Abstract][Full Text] [Related]
10. Small-cell lung cancer-associated autoantibodies: potential applications to cancer diagnosis, early detection, and therapy.
Kazarian M; Laird-Offringa IA
Mol Cancer; 2011 Mar; 10():33. PubMed ID: 21450098
[TBL] [Abstract][Full Text] [Related]
11. Antibodies against autologous tumor cell proteins in patients with small-cell lung cancer: association with improved survival.
Winter SF; Sekido Y; Minna JD; McIntire D; Johnson BE; Gazdar AF; Carbone DP
J Natl Cancer Inst; 1993 Dec; 85(24):2012-8. PubMed ID: 8246287
[TBL] [Abstract][Full Text] [Related]
12. Caveats and Pitfalls of SOX1 Autoantibody Testing With a Commercial Line Blot Assay in Paraneoplastic Neurological Investigations.
Ruiz-García R; Martínez-Hernández E; García-Ormaechea M; Español-Rego M; Sabater L; Querol L; Illa I; Dalmau J; Graus F
Front Immunol; 2019; 10():769. PubMed ID: 31031763
[TBL] [Abstract][Full Text] [Related]
13. Low titre autoantibodies against recoverin in sera of patients with small cell lung cancer but without a loss of vision.
Bazhin AV; Shifrina ON; Savchenko MS; Tikhomirova NK; Goncharskaia MA; Gorbunova VA; Senin II; Chuchalin AG; Philippov PP
Lung Cancer; 2001 Oct; 34(1):99-104. PubMed ID: 11557119
[TBL] [Abstract][Full Text] [Related]
14. Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer.
Dai L; Qu Y; Li J; Wang X; Wang K; Wang P; Jiang BH; Zhang J
Oncotarget; 2017 May; 8(22):36664-36673. PubMed ID: 28456790
[TBL] [Abstract][Full Text] [Related]
15. Serum anti-p53 antibodies in patients with lung cancer.
Mack U; Ukena D; Montenarh M; Sybrecht GW
Oncol Rep; 2000; 7(3):669-74. PubMed ID: 10767388
[TBL] [Abstract][Full Text] [Related]
16. Frequency of Synaptic Autoantibody Accompaniments and Neurological Manifestations of Thymoma.
Zekeridou A; McKeon A; Lennon VA
JAMA Neurol; 2016 Jul; 73(7):853-9. PubMed ID: 27135398
[TBL] [Abstract][Full Text] [Related]
17. Calcium channel autoantibodies in myasthenic syndrome and small cell lung cancer.
Pelucchi A; Ciceri E; Clementi F; Marazzini L; Foresi A; Sher E
Am Rev Respir Dis; 1993 May; 147(5):1229-32. PubMed ID: 8387255
[TBL] [Abstract][Full Text] [Related]
18. Role of autoantibodies and blood-brain barrier leakage in cognitive impairment in systemic lupus erythematosus.
Hanly JG; Legge A; Kamintsky L; Friedman A; Hashmi JA; Beyea SD; Fisk J; Omisade A; Calkin C; Bardouille T; Bowen C; Matheson K; Fritzler MJ
Lupus Sci Med; 2022 Jun; 9(1):. PubMed ID: 35705307
[TBL] [Abstract][Full Text] [Related]
19. Posttranslational modifications induce autoantibodies with risk prediction capability in patients with small cell lung cancer.
Lastwika KJ; Kunihiro A; Solan JL; Zhang Y; Taverne LR; Shelley D; Rho JH; Randolph TW; Li CI; Grogan EL; Massion PP; Fitzpatrick AL; MacPherson D; Houghton AM; Lampe PD
Sci Transl Med; 2023 Jan; 15(678):eadd8469. PubMed ID: 36630482
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of Cognitive Impairment and Association With Survival Among Older Patients With Hematologic Cancers.
Hshieh TT; Jung WF; Grande LJ; Chen J; Stone RM; Soiffer RJ; Driver JA; Abel GA
JAMA Oncol; 2018 May; 4(5):686-693. PubMed ID: 29494732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
